C/EBPα缺失与急性髓系白血病的良好预后：一个生物学悖论。 - Suppr | 超能文献

Loss of C/EBP alpha and favorable prognosis of acute myeloid leukemias: a biological paradox.

作者信息

Perrotti Danilo, Marcucci Guido, Caligiuri Michael A

出版信息

J Clin Oncol. 2004 Feb 15;22(4):582-4. doi: 10.1200/JCO.2004.12.965. Epub 2004 Jan 15.

DOI:10.1200/JCO.2004.12.965

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Loss of C/EBP alpha and favorable prognosis of acute myeloid leukemias: a biological paradox.C/EBPα缺失与急性髓系白血病的良好预后：一个生物学悖论。

J Clin Oncol. 2004 Feb 15;22(4):582-4. doi: 10.1200/JCO.2004.12.965. Epub 2004 Jan 15.

2

CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations.年轻成人急性髓系白血病且细胞遗传学正常患者中的CEBPA突变：预后相关性及协同突变分析

J Clin Oncol. 2004 Feb 15;22(4):624-33. doi: 10.1200/JCO.2004.06.060. Epub 2004 Jan 15.

3

Decreased expression of CCAAT/enhancer binding protein zeta (C/EBPzeta) in patients with different myeloid diseases.

Leuk Res. 2005 Dec;29(12):1435-41. doi: 10.1016/j.leukres.2005.05.020. Epub 2005 Jul 11.

4

CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma.急性髓系白血病、骨髓增生异常综合征、多发性骨髓瘤和非霍奇金淋巴瘤患者的CEBPA基因多态性与突变

Blood Cells Mol Dis. 2008 May-Jun;40(3):401-5. doi: 10.1016/j.bcmd.2007.11.005. Epub 2008 Jan 8.

5

Genetic changes of CEBPA in cancer: mutations or polymorphisms?

J Clin Oncol. 2007 Jun 10;25(17):2493-4; author reply 2494-5. doi: 10.1200/JCO.2007.10.7227.

6

Induction of C/EBP beta and GADD153 expression by dopamine in human neuroblastoma cells. Relationship with alpha-synuclein increase and cell damage.多巴胺诱导人神经母细胞瘤细胞中C/EBPβ和GADD153的表达。与α-突触核蛋白增加及细胞损伤的关系。

Brain Res Bull. 2005 Feb 15;65(1):87-95. doi: 10.1016/j.brainresbull.2004.11.008.

7

Induction of CCAAT/enhancer binding protein-delta by cytokinins, but not by retinoic acid, during granulocytic differentiation of human myeloid leukaemia cells.在人髓性白血病细胞的粒细胞分化过程中，细胞分裂素可诱导CCAAT/增强子结合蛋白δ的产生，而视黄酸则不能。

Br J Haematol. 2005 Feb;128(4):540-7. doi: 10.1111/j.1365-2141.2004.05326.x.

8

Risk assessment in patients with acute myeloid leukemia and a normal karyotype.急性髓系白血病且核型正常患者的风险评估

Clin Cancer Res. 2005 Feb 15;11(4):1416-24. doi: 10.1158/1078-0432.CCR-04-1552.

9

A transcriptional profiling study of CCAAT/enhancer binding protein targets identifies hepatocyte nuclear factor 3 beta as a novel tumor suppressor in lung cancer.一项关于CCAAT/增强子结合蛋白靶标的转录谱研究将肝细胞核因子3β鉴定为肺癌中的一种新型肿瘤抑制因子。

Cancer Res. 2004 Jun 15;64(12):4137-47. doi: 10.1158/0008-5472.CAN-03-4052.

10

Expression of CCAAT/enhancer binding protein delta is closely associated with degeneration of surface mucous cells of larval stomach during the metamorphosis of Xenopus laevis.在非洲爪蟾变态发育过程中，CCAAT/增强子结合蛋白δ的表达与幼体胃表面黏液细胞的退化密切相关。

Comp Biochem Physiol B Biochem Mol Biol. 2005 Mar;140(3):505-11. doi: 10.1016/j.cbpc.2004.11.015.

引用本文的文献

1

BCR-ABL1 kinase-dependent alteration of mRNA metabolism: potential alternatives for therapeutic intervention.BCR-ABL1 激酶依赖性改变 mRNA 代谢：治疗干预的潜在替代方案。

Leuk Lymphoma. 2011 Feb;52 Suppl 1(Suppl 1):30-44. doi: 10.3109/10428194.2010.546914. Epub 2011 Jan 11.

2

CEBPA gene mutational status: a complete screening using high-resolution melt curve analysis.CEBPA基因的突变状态：使用高分辨率熔解曲线分析进行全面筛查。

Mol Diagn Ther. 2009;13(3):195-200. doi: 10.2165/01250444-200913030-00004.

3

High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiation.BCR/ABL癌蛋白的高水平表达是MAPK-hnRNP-E2依赖性抑制C/EBPα驱动的髓系分化所必需的。

Blood. 2007 Aug 1;110(3):994-1003. doi: 10.1182/blood-2007-03-078303. Epub 2007 May 2.